On the public citation graph
Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
0 signed · 40 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamainternmed.2018.0292openalex-snapshot
Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function
inferredcites →https://doi.org/10.1002/cam4.3378openalex-snapshot
Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study
inferredcites →https://doi.org/10.1002/hep.27199openalex-snapshot
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes
inferredcites →https://doi.org/10.1002/hep.30833openalex-snapshot
An Aging Population of Chronic Hepatitis B With Increasing Comorbidities: A Territory‐Wide Study From 2000 to 2017
inferredcites →https://doi.org/10.1002/hsr2.352openalex-snapshot
Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
inferredcites →https://doi.org/10.1007/s10552-018-1058-4openalex-snapshot
Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer
inferredcites →https://doi.org/10.1007/s11892-017-0829-8openalex-snapshot
Metformin: New Preparations and Nonglycemic Benefits
inferredcites →https://doi.org/10.1016/j.arr.2017.08.003openalex-snapshot
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.cgh.2020.04.083openalex-snapshot
Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis–Related, Child–Pugh A Cirrhosis
inferredcites →https://doi.org/10.1016/j.diabres.2019.107843openalex-snapshot
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
inferredcites →https://doi.org/10.1016/j.jhep.2017.06.019openalex-snapshot
Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
inferredcites →https://doi.org/10.1016/j.jhep.2019.12.005openalex-snapshot
Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B
inferredcites →https://doi.org/10.1016/s0140-6736(98)07037-8openalex-snapshot
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
inferredcites →https://doi.org/10.1038/clpt.2009.92openalex-snapshot
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
inferredcites →https://doi.org/10.1042/0264-6021:3480607openalex-snapshot
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
inferredcites →https://doi.org/10.1080/01621459.1999.10474144openalex-snapshot
A Proportional Hazards Model for the Subdistribution of a Competing Risk
inferredcites →https://doi.org/10.1097/ccm.0b013e3181a02490openalex-snapshot
Metformin-associated lactic acidosis: A prognostic and therapeutic study*
inferredcites →https://doi.org/10.1111/apt.14341openalex-snapshot
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
inferredcites →https://doi.org/10.1111/apt.15331openalex-snapshot
Long‐term metformin use may improve clinical outcomes in diabetic patients with non‐alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
inferredcites →https://doi.org/10.1111/dom.12974openalex-snapshot
Metformin‐associated lactic acidosis ( MALA ): M oving towards a new paradigm
inferredcites →https://doi.org/10.1111/j.1478-3231.2010.02223.xopenalex-snapshot
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
inferredcites →https://doi.org/10.1111/liv.13872openalex-snapshot
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
inferredcites →https://doi.org/10.1124/mol.63.4.844openalex-snapshot
Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin
inferredcites →https://doi.org/10.1136/gutjnl-2011-301708openalex-snapshot
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
inferredcites →https://doi.org/10.1177/0885066605278644openalex-snapshot
Lactic Acidosis: From Sour Milk to Septic Shock
inferredcites →https://doi.org/10.1186/cc8885openalex-snapshot
Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication
inferredcites →https://doi.org/10.1210/jc.2010-2415openalex-snapshot
Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
inferredcites →https://doi.org/10.1331/japha.2010.08090openalex-snapshot
Clarifying metformin's role and risks in liver dysfunction
inferredcites →https://doi.org/10.2337/dc18-s002openalex-snapshot
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
inferredcites →https://doi.org/10.2337/dc20-s009openalex-snapshot
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4819281openalex-extracted
Evaluating Socioeconomic Disparities in Comorbid Chronic Kidney Disease and Hepatitis B or Hepatitis C Infections: A NHANES Analysis
inferred← citeshttps://doi.org/10.1016/j.jaad.2024.11.071openalex-snapshot
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations
inferred← citeshttps://doi.org/10.1016/j.jhep.2024.04.031openalex-snapshot
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
inferred← citeshttps://doi.org/10.1097/hep.0000000000000263openalex-snapshot
Diabetes and cirrhosis: Current concepts on diagnosis and management
inferred← citeshttps://doi.org/10.1111/apt.70705openalex-snapshot
Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory‐Wide Cohort Study
inferred← citeshttps://doi.org/10.1111/liv.70597openalex-snapshot
Clinical Impact and Therapeutic Management of Diabetes Mellitus in Patients With Decompensated Cirrhosis
inferred← citeshttps://doi.org/10.1159/000539371openalex-snapshot
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
inferred← citeshttps://doi.org/10.15212/cvia.2023.0073openalex-snapshot
Population-Based Clinical Studies Using Routinely Collected Data in Hong Kong, China: A Systematic Review of Trends and Established Local Practices
showing the first 8 of 9 · page through all 9
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.